Reply to: Metformin use and keratinocyte carcinoma risk

J Am Acad Dermatol. 2021 Oct;85(4):e265. doi: 10.1016/j.jaad.2021.05.028. Epub 2021 May 27.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carcinoma, Basal Cell* / chemically induced
  • Carcinoma, Basal Cell* / epidemiology
  • Humans
  • Keratinocytes
  • Metformin* / adverse effects
  • Skin Neoplasms* / chemically induced
  • Skin Neoplasms* / epidemiology

Substances

  • Metformin